We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$24.1B
AUM Growth
+$1.97B
Cap. Flow
+$2.05B
Cap. Flow %
8.49%
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,118
Increased
953
Reduced
622
Closed
747

Sector Composition

Rank Sector Weight
1 Healthcare 20.28%
2 Financials 16.56%
3 Technology 13.74%
4 Consumer Discretionary 11.01%
5 Communication Services 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PYPL icon
926
PUT
PayPal
PYPL
$49.8B
$5M 0.02%
19,200
-16,600
-46% -$4.71M
IHI icon
927
iShares US Medical Devices ETF
IHI
$3.07B
$5M 0.02%
79,565
-46,273
-37% -$2.95M
ALGN icon
928
Align Technology
ALGN
$12.1B
$4.99M 0.02%
7,498
-16,702
-69% -$11.3M
EVER icon
929
EverQuote
EVER
$921M
$4.99M 0.02%
+267,870
New +$6.41M
GGPIU
930
DELISTED
Gores Guggenheim, Inc. Unit
GGPIU
$4.98M 0.02%
+467,540
New +$4.83M
FRON
931
DELISTED
Frontier Acquisition Corp. Class A Ordinary Shares
FRON
$4.97M 0.02%
512,385
+1,805
+0.4% +$17.5K
CRHC.WS
932
CALL
DELISTED
Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CRHC.WS
$4.97M 0.02%
505,916
NXPI icon
933
NXP Semiconductors
NXPI
$66.4B
$4.95M 0.02%
25,269
+23,108
+1,069% +$4.8M
VHAQ
934
DELISTED
Viveon Health Acquisition Corp.
VHAQ
$4.95M 0.02%
+495,405
New +$4.93M
XLF icon
935
PUT
State Street Financial Select Sector SPDR ETF
XLF
$56.6B
$4.95M 0.02%
131,800
-367,600
-74% -$13.8M
HWELU
936
DELISTED
Healthwell Acquisition Corp. I Unit
HWELU
$4.95M 0.02%
+502,780
New +$4.98M
EDNCU
937
DELISTED
Endurance Acquisition Corp. Unit
EDNCU
$4.94M 0.02%
+496,929
New +$4.93M
HD icon
938
Home Depot
HD
$337B
$4.94M 0.02%
15,062
-41,227
-73% -$13.5M
SOND
939
DELISTED
Sonder
SOND
$4.94M 0.02%
24,998
CORS
940
DELISTED
Corsair Partnering Corporation
CORS
$4.93M 0.02%
+500,089
New +$4.89M
TRCA
941
DELISTED
Twin Ridge Capital Acquisition Corp.
TRCA
$4.91M 0.02%
506,175
UBSI icon
942
United Bankshares
UBSI
$6.6B
$4.91M 0.02%
+134,906
New +$4.72M
PRTA icon
943
Prothena Corp
PRTA
$457M
$4.91M 0.02%
+68,892
New +$4.28M
SNTI icon
944
Senti Biosciences Holdings
SNTI
$12.3M
$4.91M 0.02%
49,359
+9,359
+23% +$923K
FLGT icon
945
Fulgent Genetics
FLGT
$552M
$4.9M 0.02%
54,486
+47,663
+699% +$4.33M
WARR.WS
946
CALL
DELISTED
Warrior Technologies Acquisition Company Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
WARR.WS
$4.9M 0.02%
499,490
+37,058
+8% +$25K
AVAN.WS
947
CALL
DELISTED
Avanti Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AVAN.WS
$4.89M 0.02%
499,997
PLAY icon
948
Dave & Buster's
PLAY
$356M
$4.89M 0.02%
127,710
+90,450
+243% +$3.27M
DBI icon
949
Designer Brands
DBI
$292M
$4.88M 0.02%
350,331
-84,528
-19% -$1.22M
TLGA.WS
950
CALL
DELISTED
TLG Acquisition One Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
TLGA.WS
$4.88M 0.02%
495,426
+98,145
+25% +$68.8K

Similar funds

Marshall Wace's Q3 2021 Portfolio in Review

As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $2.05B of net new capital in Q3 2021, opening 1,118 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.

  • Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
  • Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
  • Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
  • Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
  • Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
  • Marshall Wace opened 1,118 new positions and closed 747 in Q3 2021.
  • Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.